CD4 T-cell regeneration in HIV-1 elite controllers

AIDS

Volumn 26, Issue 6, 2012, Pages 701-706

  Yang, Yue ^a,b   Al Mozaini, Maha ^a,b,c   Buzon, Maria J ^a,b   Beamon, Jill ^a   Ferrando Martinez, Sara ^d,e   Ruiz Mateos, Ezequiel ^e   Rosenberg, Eric S ^a   Pereyra, Florencia ^b   Yu, Xu G ^b   Lichterfeld, Mathias ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

elite controllers; HIV 1; naive T cells; thymic function

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 7; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ELITE CONTROLLER; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL RECEPTOR EXCISION CIRCLE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS FUNCTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIGENS, CD38; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE KINASES; VIRUS REPLICATION;

EID: 84862832351     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283519b22     Document Type: Article

References (19)

1. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive Tcell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-2066.
2. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA. Altered representation ofnaive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest 1995; 95:2054-2060.
3. Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2002; 2:547-556. (Pubitemid 37328730)
4. Haines CJ, Giffon TD, Lu LS, Lu X, Tessier-Lavigne M, Ross DT, Lewis DB. Human CD4+ Tcell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J Exp Med 2009; 206:275-285.
5. Spits H. Development of alphabeta Tcells in the human thymus. Nat Rev Immunol 2002; 2:760-772. (Pubitemid 37328716)
6. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes inthymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695. (Pubitemid 29003949)
7. Dion ML, Bordi R, Zeidan J, Asaad R, Boulassel MR, Routy JP, et al. Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood 2007; 109:2912-2920. (Pubitemid 46482088)
8. Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, Kettaf N, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004; 21:757-768. (Pubitemid 39626667)
9. Saez-Cirion A, Pancino G, Sinet M, Venet A, Lambotte O. HIV controllers: how dothey tame the virus? Trends Immunol 2007; 28:532-540.
10. Migueles SA, Connors M. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 2010; 304:194-201.
11. Blankson JN. Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? Antiviral Res 2009.
12. Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, Cote P, et al. T cell activation does not drive CD4 decline in longitudinally followed HIV-infected elite controllers. AIDS Res Ther 2011; 8:20.
13. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page- Shafer K, et al. Relationship between Tcell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197:126-133. (Pubitemid 351263476)
14. Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, et al. Clinical outcomes ofelite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis 2009; 200:1714-1723.
15. Sedaghat AR, Rastegar DA, O'Connell KA, Dinoso JB, Wilke CO, Blankson JN. T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin Infect Dis 2009; 49:1763-1766.
16. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, et al. Selective depletion ofhigh-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8R+ T cells after early HIV-1 infection. J Virol 2007; 81:4199-4214. (Pubitemid 46586914)
17. Ferrando-Martinez S, Franco JM, Ruiz-Mateos E, Hernandez A, Ordonez A, Gutierrez E, Leal M. A reliable and simplified sj/beta-TREC ratio quantification method for human thymic output measurement. J Immunol Methods 2010; 352:111-117.
18. Almeida AR, Borghans JA, Freitas AA. T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med 2001; 194:591-599. (Pubitemid 32844770)
19. Pereyra F, Palmer S, Miura T, Block BL, Wiegand A, Rothchild AC, et al. Persistent low-level viremia inHIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis 2009; 200:984-990.